Beta-Lapachone,4707-32-8
- 品牌:absin
- 型号:abs813518
- 产地:中国
- 供应商:爱必信(上海)生物科技有限公司
- 供应商报价:¥480
- 标签:Beta-Lapachone,4707-32-8、Beta-Lapachone,4707-32-8价格、Beta-Lapachone,4707-32-8厂家、β-拉帕醌;ARQ-501;NSC-26326;NSC-629749;SL-11001;beta-lapachone、Absin、爱必信(上海)生物科技有限公司
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
YZ剂描述: 产品名称:Beta-Lapachone 产品别名:β-拉帕醌 英文别名:ARQ-501;NSC-26326;NSC-629749;SL-11001;beta-lapachone 靶点:Topo I ,IDO1 CAS:4707-32-8 纯度:>98% 外观:见爱必信官网 保存方法:store at -20℃ for one year(Powder); in DMSO or others solvent store at 2-4℃ for two weeks, at -20℃ for six months. 描述: Beta-Lapachone是一种选择性的DNA topoisomerase I(DNA拓扑异构酶I)YZ剂,对DNA拓扑异构酶II或连接酶无YZ作用。Beta-LapachoneYZDNA topoisomerase I诱导的DNA松弛,这种作用具有剂量依赖性。Beta-Lapachone (100 nM或更高)处理,与对照组相比,YZ95%以上Topo I DNA舒展活性。Beta-Lapachone(1-5 μM)作用于HL-60和三种前列腺癌(DU-145, PC-3, 和LNCaP)细胞,使细胞周期停滞在G0/G1期,并通过锁定Topo I在DNA上和阻止复制叉移动,而诱导细胞凋亡。 溶解性:Ethanol :12.1 mg/mL (50 mM) 体外研究: Beta-Lapachone inhibits DNA relaxation induced by DNA topoisomerase I in a dose-dependent manner. Treatment of beta-lapachone (100 nM or greater) results in >95% inhibition of Topo I DNA unwinding activity compared to the DMSO control. beta-lapachone (1-5 μM) causes a block in G0/G1 of the cell cycle and induces apoptosis by locking Topo I onto DNA and blocking replication fork movement in HL-60 and three human prostate cancer (DU-145, PC-3, and LNCaP) cells. Beta-Lapachone facilitates the migration of mouse 3T3 fibroblasts and human endothelial EAhy926 cells through different MAPK signaling pathways, and thus accelerates scrape-wound healing in vitro. In addition, beta-Lapachone inhibits purified recombinant IDO1 activity through uncompetitive inhibition with IC50 of 0.44 μM, and beta-lapachone also exhibits superior retention of intracellular IDO1 inhibitory activity with an IC50 of 1.0 μM, partially dependent on biotransformation by NQO1. Beta-lapachone induces programmed necrosis of NQO1+ cancer cells by NQO1-dependent reactive oxygen species (ROS) formation and PARP1 hyperactivation. 体内研究:Beta-lapachone treatment (50 mg/kg) leads to potent inhibition of in vivo tumor growth in a xenograft mouse model of human ovarian cancer, and the combination of beta-lapachone and taxol produces a synergistic induction of apoptosis. In normal and diabetic (db/db) mice, treatment of beta-lapachone results in a faster healing process than vehicle only. 产品信息订购:
产品更多信息请进入爱必信网站咨询 |